NasdaqCM - Nasdaq Real Time Price USD

Cardio Diagnostics Holdings, Inc. (CDIOW)

0.0172

-0.0001

(-0.58%)

As of 9:59:33 AM EDT. Market Open.

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

CHICAGO, May 08, 2025--Cardio Diagnostics Holdings today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025.

Business Wire 8 days ago

CDIO

CDIOW
-0.58%
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session

CHICAGO, March 26, 2025--Cardio Diagnostics will showcase its growing portfolio of advanced cardiovascular solutions at the ACC's 74th Annual Scientific Session & Expo.

Business Wire last month

CDIO

CDIOW
-0.58%
Cardio Diagnostics Holdings Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Cardio Diagnostics Holdings ( NASDAQ:CDIO ) Full Year 2024 Results Key Financial Results Net loss: US$8.38m (flat on FY...

Simply Wall St. last month

CDIO

CDIOW
-0.58%
Is Cardio Diagnostics Holdings, Inc. (CDIO) The Best Day Trading Stock To Invest In Now?

We recently published a list of 10 Best Day Trading Stocks To Invest In Now. In this article, we are going to take a look at where Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) stands against other best day trading stocks to invest in now. Over the past few years, retail traders have penetrated the stock markets […]

Insider Monkey 2 months ago

CDIOW
-0.58%
Cardio Diagnostics Holdings, Inc. (CDIO) Expands AI-Driven Heart Disease Testing with 7 New Partnerships

We recently compiled a list of the 9 AI Stocks Investors Are Monitoring. In this article, we are going to take a look at where Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) stands against the other AI stocks. The European Commission has recently issued guidelines intended to standardize rules across the AI industry in Europe. As reported by […]

Insider Monkey 3 months ago

CDIOW
-0.58%
Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

CHICAGO, February 04, 2025--Cardio Diagnostics has announced that the Company has partnered with seven new provider organizations.

Business Wire 3 months ago

CDIO

CDIOW
-0.58%
Cardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests

We recently compiled a list of the Top 12 AI Stock News and Ratings Dominating Wall Street. In this article, we are going to take a look at where Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) stands against the other AI stocks. There is a growing concern in Silicon Valley that the progress around artificial intelligence is slowly “losing […]

Insider Monkey 4 months ago

CDIOW
-0.58%
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

CHICAGO, December 16, 2024--Cardio Diagnostics announced their PrecisionCHD and Epi+Gen CHD tests have received final pricing determinations from CMS.

Business Wire 4 months ago

CDIO

CDIOW
-0.58%
Cardio Diagnostics Holdings Third Quarter 2024 Earnings: Misses Expectations

Cardio Diagnostics Holdings ( NASDAQ:CDIO ) Third Quarter 2024 Results Key Financial Results Net loss: US$1.41m (loss...

Simply Wall St. 5 months ago

CDIO

CDIOW
-0.58%
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

CHICAGO, November 12, 2024--Cardio Diagnostics will sponsor and exhibit at the Florida Association of ACOs (FLAACOs) 2024 Annual Fall Conference.

Business Wire 5 months ago

CDIO

CDIOW
-0.58%
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

CHICAGO, October 01, 2024--Cardio Diagnostics' PrecisionCHD and Epi+Gen CHD tests have received preliminary pricing determinations from CMS.

Business Wire 7 months ago

CDIO

CDIOW
-0.58%
Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease Tests

CHICAGO, IL / ACCESSWIRE / September 17, 2024 / By James Blacker, Benzinga Cardio Diagnostics (NASDAQ:CDIO), the company leveraging AI to revolutionize cardiovascular disease prevention with precision epigenetics, is awaiting a crucial decision that ...

ACCESS Newswire 7 months ago

CDIO

CDIOW
-0.58%
Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

CHICAGO, July 29, 2024--CDIO.AI emphasizes Cardio Diagnostics' AI-first, scalable solutions for preventing, detecting and managing cardiovascular disease.

Business Wire 9 months ago

CDIO

CDIOW
-0.58%
Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

CHICAGO, June 27, 2024--Cardio Diagnostics' clinical blood test, Epi+Gen CHD is now available at FMS' retail clinical location at the Meijer Supercenter in McHenry, IL.

Business Wire 10 months ago

CDIO

CDIOW
-0.58%
Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum

CHICAGO, June 25, 2024--Cardio Diagnostics will sponsor a booth and showcase its groundbreaking cardiovascular solutions at the 2024 Onsite Employee Health Clinics Forum.

Business Wire 10 months ago

CDIO

CDIOW
-0.58%
Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

CHICAGO, June 10, 2024--Cardio Diagnostics today announced the successful completion of its System and Organization Controls (SOC) 2 Type I audit.

Business Wire 10 months ago

CDIO

CDIOW
-0.58%
Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

CHICAGO, May 21, 2024--Cardio Diagnostics will recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the MolDx program.

Business Wire 11 months ago

CDIO

CDIOW
-0.58%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Cardio Diagnostics Holdings, Inc. (CDIOW)

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session

Cardio Diagnostics Holdings Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Is Cardio Diagnostics Holdings, Inc. (CDIO) The Best Day Trading Stock To Invest In Now?

Cardio Diagnostics Holdings, Inc. (CDIO) Expands AI-Driven Heart Disease Testing with 7 New Partnerships

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Cardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Cardio Diagnostics Holdings Third Quarter 2024 Earnings: Misses Expectations

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease Tests

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests